Medication options for Parkinson’s disease (PD) are constantly evolving and vary for each individual. Choosing medications depends on many variables; including motor fluctuations, symptom variability and other existing health issues. In this webinar, Dr. Rajesh Pahwa shares new treatment options to be on the lookout for within the next two years and explains who would be the best candidates for these new therapies available.
Rajesh Pahwa, MD
Laverne and Joyce Rider Professor of Neurology
Chief, Parkinson and Movement Disorder Division
Director, Parkinson’s Foundation Center of Excellence
University of Kansas Medical Center